| 肺原性心脏病患者骨代谢的改变 |
| |
| 引用本文： | 白孟海,葛宝丰,郭永忠,高梅,陈克明,王琦,刘剑梅.肺原性心脏病患者骨代谢的改变[J].中国骨伤,2003,16(2):65-66. |
| |
| 作者姓名： | 白孟海 葛宝丰 郭永忠 高梅 陈克明 王琦 刘剑梅 |
| |
| 作者单位： | 兰州军区兰州总医院创伤外科研究所,甘肃,兰州,730050 |
| |
| 摘 要： | 目的 通过对肺原性心脏病患者尿脱氧吡啶酚的测定了解骨代谢情况。方法 采用酶联免疫法测定了 2 3例肺心病 (男 13例 ,女 10例 )患者的尿脱氧吡啶酚浓度与 2 3例正常人进行比较。结果 肺原性心脏病患者与对照组的尿脱氧吡啶酚排泄率分别为 :男 :95 82± 3 6 11,66 80± 2 1 97(t =2 417) ;女 :10 3 99± 3 4 47,65 79± 2 1 98(t=3 0 3 7)。肺心病患者的尿脱氧吡啶酚排泄率与对照组比较差异有显著性 (P <0 0 5 )。结论 肺原性心脏病患者 ,由于长期慢性缺氧等因素 ,致尿脱氧吡啶酚水平明显增高。提示该组患者骨吸收增加
|
| 关 键 词： | 肺原性心脏病 骨代谢 尿脱氧吡啶酚 酶联免疫吸附 测定 |
| 收稿时间： | 2001/9/15 0:00:00 |
| 修稿时间： | 2001年9月15日 |
Variations of bone metabolism in patients with pulmonary heart disease |
| |
| BAI Menghai,GE Baofeng,GUO Yongzhong.Variations of bone metabolism in patients with pulmonary heart disease[J].China Journal of Orthopaedics and Traumatology,2003,16(2):65-66. |
| |
| Authors: | BAI Menghai GE Baofeng GUO Yongzhong |
| |
| Institution: | BAI Menghai,GE Baofeng,GUO Yongzhong,et al.Instinlte of Orthopaedics,General Hospital of PLA |
| |
| Abstract: | Objective:To study diagnostic value of urine deoxypyridinoline for the detection of bone metabolism in cases of pulmonary heart disease Methods:Urine deoxypyridinoline was assayed by ELISA in 23 patients of pulmonary heart disease (males 13,females 10) and 23 normal persons served as control.Results:The urine deoxypyridinoline of males was 95.82±36.11 and of control group 66.80±21.97 (t=2.417).In the females,it was 103.99±34.47 and 65.79±21.98(t=3.307) respectively.All the data had significant difference with the Results of control group.Conclusion:The urine deoxypyridinoline of patients with pulmonary heart disease was higher because of the long period of chronic lack of oxygen indicating an increased rate of bone absorption. |
| |
| Keywords: | Pulmonary heart disease ELISA Bone metabolism |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《中国骨伤》浏览原始摘要信息 |
| 点击此处可从《中国骨伤》下载免费的PDF全文 |
|
